Computer Enabled Neuroplasticity Treatment (CENT)

Not Applicable

Completed

• Conditions: Attention Deficit/Hyperactivity Disorder (ADHD); Mental and Behavioural Disorders; Disturbance of activity and attention

• Registration Number: ISRCTN13915109
• Lead Sponsor: niversity of Helsinki

Brief Summary

2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27242472 results 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34276325/ (added 10/10/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-09-22
• Study Completion: 2016-06-01
• Last Update Posted: 23 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

1. Pre-existing diagnosis of ADHD
2. Nonexistence of neurological diagnoses
3. IQ score > 80 measured by a qualified psychologist using WAIS IV
4. Scores on ASRS and BADDS indicating presence of ADHD

Exclusion Criteria

Extreme outlier scores in the scales of
1. Generalized Anxiety Disorder (Spitzer et al., 2006)
2. Beck Depression Inventory (Beck et al., 1996)
3. Alcohol Use Disorders Identification Test (Saunders et al., 1993)
4. The Mood Disorder Questionnaire (Robert et al., 2000)
5. Test of prodromal symptoms of psychosis (Heinimaa et al., 2003)
6. Dissociative experiences scale (Liebowitz, 1992) for dissociative symptoms

Thresholds for exclusion were not fixed but at the discretion of the consulting psychiatrist. Use of medication for ADHD was not an exclusion criterion but participants were asked not to make changes in medication during the time of the training.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Self-report of ADHD symptoms, using Brown Attention Deficit Disorder Scale (BADDS) to be measured at baseline, post-treatment 1 year after baseline, and follow-up 2.5 years after treatment<br> 2. Adult ADHD Self Report Scale (ASRS) to be measured at the same timepoints as BADDS<br> 3. Objective measure of attention, using the computerised Test Of Variables of Attention (TOVA), to be completed at baseline and post-treatment<br>

Secondary Outcome Measures

Name	Time	Method
Treatment group records of performance during neurofeedback ('learning curves').